4.5 Article

Anti-retinal IgG antibodies in patients with early and advanced type 2 macular telangiectasia

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Serine and Lipid Metabolism in Macular Disease and Peripheral Neuropathy

Marin L. Gantner et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Multidisciplinary Sciences

Testosterone is an endogenous regulator of BAFF and splenic B cell number

Anna S. Wilhelmson et al.

NATURE COMMUNICATIONS (2018)

Review Physiology

The evolution of greater humoral immunity in females than males: implications for vaccine efficacy

Ashley L. Fink et al.

CURRENT OPINION IN PHYSIOLOGY (2018)

Review Immunology

Sex differences in immune responses

Sabra L. Klein et al.

NATURE REVIEWS IMMUNOLOGY (2016)

Review Ophthalmology

Latest Updates on Antiretinal Autoantibodies Associated With Vision Loss and Breast Cancer

Grazyna Adamus

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)

Article Ophthalmology

Macular telangiectasia type 2

Peter Charbel Issa et al.

PROGRESS IN RETINAL AND EYE RESEARCH (2013)

Article Ophthalmology

Anti-Retinal Antibodies in Patients With Macular Telangiectasia Type 2

Ling Zhu et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)

Article Pathology

Identification of anti-retinal antibodies in patients with age-related macular degeneration

Kei Morohoshi et al.

EXPERIMENTAL AND MOLECULAR PATHOLOGY (2012)

Article Ophthalmology

Perifoveal Muller Cell Depletion in a Case of Macular Telangiectasia Type 2

Michael B. Powner et al.

OPHTHALMOLOGY (2010)

Article Ophthalmology

Retinal autoantibody profile in early age-related macular degeneration: preliminary findings from the Blue Mountains Eye Study

Svetlana Cherepanoff et al.

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2006)